secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0001437749-24-022667
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen dismisses WithumSmith+Brown, appoints KPMG as new auditor
------------------------------------------------------------------

- Dismissed WithumSmith+Brown, PC as auditor effective July 8, 2024, after competitive selection process by Audit Committee.
- No disagreements or reportable events between Company and Withum for fiscal years ended March 31, 2024 and 2023.
- Withum's 2023 audit report included going concern paragraph; 2024 report did not.
- Engaged KPMG LLP as new independent registered public accounting firm for fiscal year ending March 31, 2025.
- No prior consultations with KPMG on accounting principles, disagreements, or reportable events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000143774924022667/0001437749-24-022667-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000143774924022667/vtgn20240711_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-022667

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer